Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care.

Identifieur interne : 003D66 ( Main/Exploration ); précédent : 003D65; suivant : 003D67

Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care.

Auteurs : Sandra C. Hayes [Australie] ; Karin Johansson ; Nicole L. Stout ; Robert Prosnitz ; Jane M. Armer ; Sheryl Gabram ; Kathryn H. Schmitz

Source :

RBID : pubmed:22488698

Descripteurs français

English descriptors

Abstract

The purpose of this paper is to review the incidence of upper-body morbidity (arm and breast symptoms, impairments, and lymphedema), methods for diagnosis, and prevention and treatment strategies. It was also the purpose to highlight the evidence base for integration of prospective surveillance for upper-body morbidity within standard clinical care of women with breast cancer. Between 10% and 64% of women report upper-body symptoms between 6 months and 3 years after breast cancer, and approximately 20% develop lymphedema. Symptoms remain common into longer-term survivorship, and although lymphedema may be transient for some, those who present with mild lymphedema are at increased risk of developing moderate to severe lymphedema. The etiology of morbidity seems to be multifactorial, with the most consistent risk factors being those associated with extent of treatment. However, known risk factors cannot reliably distinguish between those who will and will not develop upper-body morbidity. Upper-body morbidity may be treatable with physical therapy. There is also evidence in support of integrating regular surveillance for upper-body morbidity into the routine care provided to women with breast cancer, with early diagnosis potentially contributing to more effective management and prevention of progression of these conditions.

DOI: 10.1002/cncr.27467
PubMed: 22488698


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care.</title>
<author>
<name sortKey="Hayes, Sandra C" sort="Hayes, Sandra C" uniqKey="Hayes S" first="Sandra C" last="Hayes">Sandra C. Hayes</name>
<affiliation wicri:level="1">
<nlm:affiliation>Queensland University of Technology, Institute of Health and Biomedical Innovation, School of Public Health, Brisbane, Australia. sc.hayes@qut.edu.au</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Queensland University of Technology, Institute of Health and Biomedical Innovation, School of Public Health, Brisbane</wicri:regionArea>
<wicri:noRegion>Brisbane</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Johansson, Karin" sort="Johansson, Karin" uniqKey="Johansson K" first="Karin" last="Johansson">Karin Johansson</name>
</author>
<author>
<name sortKey="Stout, Nicole L" sort="Stout, Nicole L" uniqKey="Stout N" first="Nicole L" last="Stout">Nicole L. Stout</name>
</author>
<author>
<name sortKey="Prosnitz, Robert" sort="Prosnitz, Robert" uniqKey="Prosnitz R" first="Robert" last="Prosnitz">Robert Prosnitz</name>
</author>
<author>
<name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name>
</author>
<author>
<name sortKey="Gabram, Sheryl" sort="Gabram, Sheryl" uniqKey="Gabram S" first="Sheryl" last="Gabram">Sheryl Gabram</name>
</author>
<author>
<name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H" last="Schmitz">Kathryn H. Schmitz</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22488698</idno>
<idno type="pmid">22488698</idno>
<idno type="doi">10.1002/cncr.27467</idno>
<idno type="wicri:Area/PubMed/Corpus">002171</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002171</idno>
<idno type="wicri:Area/PubMed/Curation">002171</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002171</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002171</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002171</idno>
<idno type="wicri:Area/Ncbi/Merge">004C54</idno>
<idno type="wicri:Area/Ncbi/Curation">004C54</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004C54</idno>
<idno type="wicri:Area/Main/Merge">003D78</idno>
<idno type="wicri:Area/Main/Curation">003D66</idno>
<idno type="wicri:Area/Main/Exploration">003D66</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care.</title>
<author>
<name sortKey="Hayes, Sandra C" sort="Hayes, Sandra C" uniqKey="Hayes S" first="Sandra C" last="Hayes">Sandra C. Hayes</name>
<affiliation wicri:level="1">
<nlm:affiliation>Queensland University of Technology, Institute of Health and Biomedical Innovation, School of Public Health, Brisbane, Australia. sc.hayes@qut.edu.au</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Queensland University of Technology, Institute of Health and Biomedical Innovation, School of Public Health, Brisbane</wicri:regionArea>
<wicri:noRegion>Brisbane</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Johansson, Karin" sort="Johansson, Karin" uniqKey="Johansson K" first="Karin" last="Johansson">Karin Johansson</name>
</author>
<author>
<name sortKey="Stout, Nicole L" sort="Stout, Nicole L" uniqKey="Stout N" first="Nicole L" last="Stout">Nicole L. Stout</name>
</author>
<author>
<name sortKey="Prosnitz, Robert" sort="Prosnitz, Robert" uniqKey="Prosnitz R" first="Robert" last="Prosnitz">Robert Prosnitz</name>
</author>
<author>
<name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name>
</author>
<author>
<name sortKey="Gabram, Sheryl" sort="Gabram, Sheryl" uniqKey="Gabram S" first="Sheryl" last="Gabram">Sheryl Gabram</name>
</author>
<author>
<name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H" last="Schmitz">Kathryn H. Schmitz</name>
</author>
</analytic>
<series>
<title level="j">Cancer</title>
<idno type="eISSN">1097-0142</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>American Cancer Society</term>
<term>Breast Neoplasms (mortality)</term>
<term>Breast Neoplasms (rehabilitation)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Congresses as Topic</term>
<term>Delivery of Health Care, Integrated (organization & administration)</term>
<term>Disability Evaluation</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Incidence</term>
<term>Longitudinal Studies</term>
<term>Lymphedema (epidemiology)</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (rehabilitation)</term>
<term>Mastectomy (adverse effects)</term>
<term>Mastectomy (methods)</term>
<term>Mastectomy (rehabilitation)</term>
<term>Middle Aged</term>
<term>Models, Organizational</term>
<term>Muscle Weakness (epidemiology)</term>
<term>Muscle Weakness (etiology)</term>
<term>Muscle Weakness (rehabilitation)</term>
<term>Pain (epidemiology)</term>
<term>Pain (etiology)</term>
<term>Pain (rehabilitation)</term>
<term>Postoperative Complications (epidemiology)</term>
<term>Postoperative Complications (prevention & control)</term>
<term>Primary Prevention (methods)</term>
<term>Prospective Studies</term>
<term>Quality of Life</term>
<term>Range of Motion, Articular (physiology)</term>
<term>Severity of Illness Index</term>
<term>Time Factors</term>
<term>Upper Extremity (physiopathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Amplitude articulaire (physiologie)</term>
<term>Complications postopératoires ()</term>
<term>Complications postopératoires (épidémiologie)</term>
<term>Congrès comme sujet</term>
<term>Douleur (rééducation et réadaptation)</term>
<term>Douleur (épidémiologie)</term>
<term>Douleur (étiologie)</term>
<term>Facteurs temps</term>
<term>Faiblesse musculaire (rééducation et réadaptation)</term>
<term>Faiblesse musculaire (épidémiologie)</term>
<term>Faiblesse musculaire (étiologie)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Indice de gravité médicale</term>
<term>Lymphoedème (rééducation et réadaptation)</term>
<term>Lymphoedème (épidémiologie)</term>
<term>Lymphoedème (étiologie)</term>
<term>Mastectomie ()</term>
<term>Mastectomie (effets indésirables)</term>
<term>Mastectomie (rééducation et réadaptation)</term>
<term>Membre supérieur (physiopathologie)</term>
<term>Modèles d'organisation</term>
<term>Prestation intégrée de soins de santé (organisation et administration)</term>
<term>Prévention primaire ()</term>
<term>Qualité de vie</term>
<term>Société américaine du cancer</term>
<term>Sujet âgé</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (mortalité)</term>
<term>Tumeurs du sein (rééducation et réadaptation)</term>
<term>Études de suivi</term>
<term>Études longitudinales</term>
<term>Études prospectives</term>
<term>Évaluation de l'incapacité</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Mastectomy</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Mastectomie</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Lymphedema</term>
<term>Muscle Weakness</term>
<term>Pain</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Lymphedema</term>
<term>Muscle Weakness</term>
<term>Pain</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Mastectomy</term>
<term>Primary Prevention</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr">
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr">
<term>Prestation intégrée de soins de santé</term>
</keywords>
<keywords scheme="MESH" qualifier="organization & administration" xml:lang="en">
<term>Delivery of Health Care, Integrated</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Amplitude articulaire</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Range of Motion, Articular</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr">
<term>Membre supérieur</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Upper Extremity</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en">
<term>Breast Neoplasms</term>
<term>Lymphedema</term>
<term>Mastectomy</term>
<term>Muscle Weakness</term>
<term>Pain</term>
</keywords>
<keywords scheme="MESH" qualifier="rééducation et réadaptation" xml:lang="fr">
<term>Douleur</term>
<term>Faiblesse musculaire</term>
<term>Lymphoedème</term>
<term>Mastectomie</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Complications postopératoires</term>
<term>Douleur</term>
<term>Faiblesse musculaire</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Douleur</term>
<term>Faiblesse musculaire</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>American Cancer Society</term>
<term>Congresses as Topic</term>
<term>Disability Evaluation</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Incidence</term>
<term>Longitudinal Studies</term>
<term>Middle Aged</term>
<term>Models, Organizational</term>
<term>Prospective Studies</term>
<term>Quality of Life</term>
<term>Severity of Illness Index</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Complications postopératoires</term>
<term>Congrès comme sujet</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Indice de gravité médicale</term>
<term>Mastectomie</term>
<term>Modèles d'organisation</term>
<term>Prévention primaire</term>
<term>Qualité de vie</term>
<term>Société américaine du cancer</term>
<term>Sujet âgé</term>
<term>Tumeurs du sein</term>
<term>Études de suivi</term>
<term>Études longitudinales</term>
<term>Études prospectives</term>
<term>Évaluation de l'incapacité</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The purpose of this paper is to review the incidence of upper-body morbidity (arm and breast symptoms, impairments, and lymphedema), methods for diagnosis, and prevention and treatment strategies. It was also the purpose to highlight the evidence base for integration of prospective surveillance for upper-body morbidity within standard clinical care of women with breast cancer. Between 10% and 64% of women report upper-body symptoms between 6 months and 3 years after breast cancer, and approximately 20% develop lymphedema. Symptoms remain common into longer-term survivorship, and although lymphedema may be transient for some, those who present with mild lymphedema are at increased risk of developing moderate to severe lymphedema. The etiology of morbidity seems to be multifactorial, with the most consistent risk factors being those associated with extent of treatment. However, known risk factors cannot reliably distinguish between those who will and will not develop upper-body morbidity. Upper-body morbidity may be treatable with physical therapy. There is also evidence in support of integrating regular surveillance for upper-body morbidity into the routine care provided to women with breast cancer, with early diagnosis potentially contributing to more effective management and prevention of progression of these conditions.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name>
<name sortKey="Gabram, Sheryl" sort="Gabram, Sheryl" uniqKey="Gabram S" first="Sheryl" last="Gabram">Sheryl Gabram</name>
<name sortKey="Johansson, Karin" sort="Johansson, Karin" uniqKey="Johansson K" first="Karin" last="Johansson">Karin Johansson</name>
<name sortKey="Prosnitz, Robert" sort="Prosnitz, Robert" uniqKey="Prosnitz R" first="Robert" last="Prosnitz">Robert Prosnitz</name>
<name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H" last="Schmitz">Kathryn H. Schmitz</name>
<name sortKey="Stout, Nicole L" sort="Stout, Nicole L" uniqKey="Stout N" first="Nicole L" last="Stout">Nicole L. Stout</name>
</noCountry>
<country name="Australie">
<noRegion>
<name sortKey="Hayes, Sandra C" sort="Hayes, Sandra C" uniqKey="Hayes S" first="Sandra C" last="Hayes">Sandra C. Hayes</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D66 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003D66 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:22488698
   |texte=   Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:22488698" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024